DelveInsight’s “Neuromodulation Devices Market Insights, Competitive Landscape, and Market Forecast – 2026” provides a comprehensive analysis of the historical and forecasted Neuromodulation Devices Market Trends in the seven major markets (i.e. the US, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
The report extensively covers the Neuromodulation Devices Market share of the individual devices, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Some of the key highlights from the Neuromodulation Devices Market Insights –
- The Neuromodulation Devices Market is segmented according to the product type, end-user, applications, and also according to technology.
- Neuromodulation Devices segmentation according to the technology includes deep brain stimulation, vagus nerve stimulation, spinal cord stimulation, sacral nerve stimulation, transcranial magnetic stimulation, peripheral nerve stimulation, and others.
- The major companies in the Neuromodulation Devices Market include Micron Medical, Boston Scientific Corporation, Abbott, SensArs, SunMed, Neuronetics, Neuros Medical Inc., Wedge Therapeutics, Nevro Corporation, and others.
- Some of the key factors driving the Neuromodulation Devices Market Growth include the rising prevalence of neurological disorders, increasing research activities in the Neuromodulation Devices domain, and the growing awareness among the general public.
- The Neuromodulation Devices Market Growth will be hindered because of the high cost of neuromodulation procedures and the dearth of trained professionals.
Download the sample pages to learn more about the market dynamics and recent development @ Neuromodulation Devices Market Landscape
Neuromodulation Devices: An Overview
Neuromodulation devices are in use for spinal pain, hearing and vision loss, stroke rehabilitation, and tremor management. Neuromodulation devices can alter nerve activity, via the targeted delivery of a stimulus, which involves electrical, chemical, and other forms of stimulus, that target specific neurological sites of the Body.
Neuromodulation has been permitted for various chronic conditions involving Alzheimer’s disease, depression, chronic pain, tremor, fecal and urinary incontinence. Similarly, these devices can be used as an adjunctive treatment in the recovery from stroke.
Neuromodulation Devices Market Segmentation
- By Product type
- Invasive
- Non-invasive
- By End-User
- Hospitals
- Neurological Clinic
- Ambulatory Surgical Centers
- By Applications
- Neurology
- Cardiology
- Urology
And several others
Key Companies in the Neuromodulation Devices
- SensArs
- Neuronetics
- Neuros Medical
- Micron Medical
- NeuroPace
- Nevro Corporation
- Microport Scientific Corporation
- Wedge Therapeutics
- Microvention
- Parasym Ltd.
- B Braun
- SunMed
- Medtronic
- electroCore Inc.
- Soterix Medical
- Abbott Laboratories
- Boston Scientific Corporation
- Inspire Medical Systems Inc.
- Aleva Neurotherapeutics SA
And many others
Visit to get more details @ Neuromodulation Key Devices and Companies
Neuromodulation Devices Market Dynamics
- Market Drivers
- Rising Prevalence of Neurological Disorders
- Increasing Research Activities in the Domain
- Growing Awareness About Neurodegenerative Disorders
- Market Barriers
- High Cost of Neuromodulation Procedures
- The Dearth of Trained Professionals
Key Questions
- At what CAGR, the Neuromodulation Devices market is expected to grow in 7MM during the forecast period (2018–2026)?
- What will be the Neuromodulation Devices market share (%) distribution in 2026 in the 7MM as compared to what it was in 2018?
- What will be the Neuromodulation Devices total market size as well as market share by devices across the 7MM during the forecast period (2018–2026)?
- What will be the Neuromodulation Devices market outlook in terms of market growth and share across the 7MM during the forecast period (2018–2026)?
- How the market drivers, market barriers, and future opportunities will affect the Neuromodulation Devices market dynamics in the coming years?
Table of Contents
|
1 |
Key Insights |
|
2 |
Executive Summary of Neuromodulation Devices |
|
3 |
Neuromodulation Devices Background and Overview |
|
4 |
Neuromodulation Devices Regulatory Scenario |
|
5 |
Neuromodulation Devices Reimbursement Scenario |
|
6 |
Company Profiles |
|
7 |
Neuromodulation Devices Competitive Analysis |
|
8 |
KOL Views |
|
9 |
Neuromodulation Devices Market Analysis |
|
10 |
Country-Wise Market Size of Neuromodulation Devices in 7MM |
|
11 |
Neuromodulation Devices Market Dynamics |
|
12 |
Neuromodulation Devices PEST Analysis |
|
13 |
Conclusion and Future Perspective |
|
14 |
Appendix |
|
15 |
DelveInsight Capabilities |
|
16 |
Disclaimer |
|
17 |
About DelveInsight |
Visit for more details about the report coverage @ Neuromodulation Devices Market Insights
- Study Period: 2018 – 2026
- Geography Covered
- The US
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
- Key Companies:
- Micron Medical, Boston Scientific Corporation, Abbott, SensArs, SunMed, Neuronetics, Neuros Medical Inc., Wedge Therapeutics, Nevro Corporation, and others.
- Report Assessment
- Marketed Product profiles
- Key Products and Key Players
- Market Drivers and Barriers
- Market Forecast
- KOL’S views
Learn more about the report offerings @ Neuromodulation Devices Market Overview
Latest Healthcare Reports by DelveInsight
Total Knee Arthroplasty Market
DelveInsight’s ‘Total Knee Arthroplasty -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of Total Knee Arthroplasty and the historical and forecasted Total Knee Arthroplasty market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.
Bevacizumab Biosimilars Insight
DelveInsight’s, “Bevacizumab Biosimilar Insight, 2020,” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in the Bevacizumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight’s “Nocturnal Enuresis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Nocturnal Enuresis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Corneal Endothelial Dystrophy Market
DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Advanced Wound Care (AWC) Market
DelveInsight’s ‘Advanced Wound Care (AWC) Market Insights, Competitive Landscape, and Market Forecast-2026’ report deliver an in-depth understanding of advanced wound care and the historical and forecasted Advanced Wound Care Market Trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
- Technological Innovation Boosting Healthcare Systems
- Von Hippel-Lindau Therapeutics Market
- Fecal Incontinence Therapeutics Market
- Innovations in Diabetes management
- Major Depressive Disorder Therapeutics Market
- Virtual Clinical Trials: Future of Drug Development
- Benefits and Challenges of Technological Innovations in Healthcare
- Application of Drones in the Healthcare Sector
- Duchenne Muscular Dystrophy Therapeutics Market
- Venous Thromboembolism Treatment Market
- Top 7 Global Pharma Companies By Revenue
- Charcot-Marie-Tooth Disease Market
- Intratumoral Cancer Therapy Market
- Phenylketonuria Treatment Market
- Systemic Lupus Erythematosus Market
- Healthcare Apps Benefits and Disadvantages
- Iron Deficiency Anemia Market
- Onychomycosis Therapy Market
- Follicular Lymphoma Therapeutics Market
- Healthcare Data Breaches
Get in touch with our Business executive for Competitive Intelligence Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Information:
Shruti Thakur info@delveinsight.com +91-9650213330
Tags:
Reportedtimes, Menafn, IPS, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English
Contact Information:
Shruti Thakur info@delveinsight.com +91-9650213330
